Compare DFNS & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DFNS | CCEL |
|---|---|---|
| Founded | 2013 | 1989 |
| Country | United States | United States |
| Employees | 15 | N/A |
| Industry | Professional Services | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.2M | 29.6M |
| IPO Year | N/A | 2022 |
| Metric | DFNS | CCEL |
|---|---|---|
| Price | $0.51 | $3.53 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 9.6K |
| Earning Date | 04-09-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 3.84% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $25,384,279.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $390.96 |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $0.42 | $2.72 |
| 52 Week High | $2.68 | $5.76 |
| Indicator | DFNS | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 31.41 | 49.99 |
| Support Level | $0.44 | $3.18 |
| Resistance Level | $0.88 | $3.57 |
| Average True Range (ATR) | 0.10 | 0.30 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 14.13 | 22.73 |
T3 Defense Inc is a holding company that acquires and operates mission-critical defense businesses involved in national security programs. It focuses on manufacturers with tough customer relationships and solid order backlogs, often capacity-and resource-constrained and specialized areas such as drones and autonomous vehicles, counter-drone systems, main manufacturing, tactical robotics, and AI software and system integration. Through disciplined acquisitions, centralized capital and ideas, and decentralized day-to-day operations, it aims to strengthen essential defense capabilities and build long-term value.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.